NasdaqGS:SRRKBiotechs
Scholar Rock Insider Sales Coincide With Key Apitegromab Launch Decisions
Scholar Rock Holding's Chief Scientific Officer has executed multiple insider share sales under a pre-arranged 10b5-1 trading plan.
The transactions come as the company readies apitegromab, its muscle-targeted treatment, for potential launch in the U.S. and Europe pending regulatory approvals.
The timing links leadership share activity with a period of important commercialization preparations for the company.
Scholar Rock Holding (NasdaqGS:SRRK) is drawing fresh attention as insider trading...